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P-Selectin Mediates Ca2+-Dependent Adhesion of Activated Platelets to Many Different Types of Leukocytes: Detection by Flow Cytometry
By Lucia G. de Bruijne-Admiraal, Piet W. Modderman, Albert E.G.Kr. Von dem Borne, and Arnoud Sonnenberg Previous studies have shown that thrombin-activated platelets interact through the P-selectin with neutrophils and mohocytes. To identify other types of leukocytes capable of such an interaction. eosinophils, basophils, and lymphocytes were ikolated from whole blood. Binding of these cells to activated platelets was examined in a double immunofluorescence assay and the results show that activated platelets not only bind to neutrophils and monocytes, but also to eosinophils, basophils, and subpopulations of T lymphocytes. Using monoclonal antibodies (MoAbs) specific for subsets of T cells, we could further demonstrate that the T cells which bind activated platelets are natural killer (NK) cells and an undefihed subpopulation of CD4+ and CD8+ cells. All these interactions were dependent on divalent cations and were completely inhibited by an MoAb against P-selectin. Thus, P-selectin mediates the binding of activated platelets to many different types of leukocytes. Studies with leukocytes treated with proteases or neuraminidase have shown that the structures recognized by P-selectin are glycoproteins carrying sialic acid residues. Because the loss of binding of activated platelets to neuraminidase-treated neutrophils was almost complete, but only partial to treated eosinophils,
CTIVATED PLATELETS, but not resting platelets,
A have been shown to adhere to monocytes, neutrophils, and a small percentage of lymphocytes.' While the binding of activated platelets to motlocytes and neutrophils appears to be Ca2+-dependent, the adhesion to lymphocytes has been reported to be Ca2+-independent. Larsen et a12 and Hamburger and McEver3 demonstrated that the platelet activation antigen P-selectin4 (PADGEM protein? GMP-140,6 or CD627) plays a critical role in the interaction between platelets and both monocytes and neutrophils. This interaction could be blocked by soluble P-selectin protein and by antibodies against P-selectin. P-selectin is a 140-Kd membrane protein that is contained within the a-granules of circulating resting platelets. Upon platelet activation by strong agonists, such as thrombin, the a-granule membrane fuses with the platelet plasma membrane, which leads to the expression of P-selectin on the platelet surface.5S8 Further, P-selectin has been detected in megakaryocytes? in HEL cells,1° and in the Weibel-Palade basophils, and monocytes, the latter cell types may have different P-selectin ligands in addition to'those present on neutrophils. We found that two previously identified ligands for P-selectin, the oligosaccharides LeX and sialyl-LeX, had little or no inhibitory effect on adhesion of activated platelets to leukocytes and that binding was not inhibited by MoAbs against these oligosaccharides. In addition, there was no correlation between the expression o f Lex on several cell types and their capacity to bind activated platelets. In contrast, the expression of sialyl-Lex on cells was almost perfectly correlated with their ability to bind activated platelets. Thus, while LeX cannot be a major ligand for P-selectin, a possible role for sialyl-LeX in P-selectin-mediated adhesion processes cannot be dismissed. Finatly, activated platelets were found to bind normally to monocytes and neutrophils of patients with paroxysmal nocturnal hemoglobulinuria (PNH) and to neutrophils from which phosphatidyl inositol (PI)-linked proteins had been removed by glycosylphosphatidyl inositol-specific phospholipase C (GPI-PLC) digestion. This suggests that at least part of the Pdelectin ligands on these cells are not GPI-anchored. 6 7992 by The American Svciety of Hematology.
bodies of endothelial cells.11J2 The primary structure of P-selectin has been deduced from cDNA cloning. P-selectin is a protein with multiple domains, including a lectin domain, an epidermal growth factor (EGF) domain, nine consensus repeats related to complement binding proteins, a transmembrane domain, and a short cytoplasmic region.13
Several ligands with different characteristics have been identified to bind P-selectin: LeX,l4 ~i a l y l -L e~,~~J~ sulfated g l y~a n s ,~~J~ and sulfa tide^.^^ The Lex and sialyl-LeX are oligosaccharide structures, which are widely distributed on both glycoproteins and glycolipids of varibus cell types, including neutrophils and mohocytes. It has been suggested that Lex is a ligand for P-selectin, because the interactions of myeloid cells with thrombin-activated platelets and P-selectin-transfected COS cells were inhibited by antibodies against Lex and by soluble oligosaccharides containing the Lex ~tructure.'~ However, these data are controversional among others, because treatment of neutrophils with neuraminidase, which leaves Lex intact, destroys their capacity to bind to activated Sulfated glycans17J8 and sulfa tide^^^ are another class of ligands for P-selectin. All these molecules, like sialyl-LeX, have a negative charge, which may play a role in the interaction of P-selectin with its ligand. In the present study, resting and activated platelets were tested for their ability to adhere to various peripheral blood cells, including eosinophils, basophils, and lymphocytes, as well as a number of different hematopoietic cell lines. To quantify the interaction of platelets and nucleated cells, we have developed a double immunofluorescence staining technique that permits the simultaneous detection of two different types of single cells and of their presence in mixed-type cell aggregates. The involvement of P-selectin in the interaction of platelets with peripheral blood cells was investigated in adhesion assays using a panel of use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From anti-P-selectin monoclonal antibodies (MoAbs). Our studies show that platelets not only bind to neutrophils and monocytes, but also to eosinophils, basophils, natural killer (NK) cells, and a second as yet undefined population of lymphocytes. This adhesion is dependent on Ca2+ and is mediated by P-selectin. Furthermore, we present evidence that there is more than one ligand for P-selectin and that these ligands are not phosphatidyl inositol (PI)-linked proteins.
MATERIALS AND METHODS
MoAbs used for cell-specific staining are described in Table 1 . The MoAbs CLB-thromb/5 and CLB-thr0mb/6?~ specific for P-selectin, and the MoAbs cLB-gra11/2~~ and CLB-3B9,24 specific for CD15, were produced in our laboratory. The anti-Pselectin MoAbs RUU 1.18, RUU 2.15, and RUU 2. Resting platelets were prepared from EDTA-anticoagulated whole blood by direct fixation with paraformaldehyde (PFA) at a final concentration of 1% (wt/vol), for 10 minutes at room temperature. Platelets were washed twice with phosphate-buffered saline/lO mmol/L EDTA/ 0.2% (wt/vol) bovine serum albumin (PBS/EDTA/BSA). Activated platelets were prepared as follows: platelets were isolated from platelet-rich plasma (PRP) of EDTA-anticoagulated blood, as described by Von dem Borne et a1.% The platelets were washed three times with PBS/EDTA/BSA, resuspended in the same buffer (2 x 108/mL), and activated with 1 U/mL of human a-thrombin (Sigma Chemical, St Louis, MO) for 10 minutes at 37°C. The platelets were then washed once, fixed with PFA, and washed two additional times. For analysis by flow cytometer, platelets were incubated for 30 minutes at 22°C with W6/32, a mouse MoAb against HLA class I (see Table l ), washed, and stained with a phycoerythrin-labeled rat MoAb against the K light chain of mouse immunoglobulin (Becton Dickinson, Mountain View, CA). Then, the platelets were washed and incubated with a mixture of irrelevant mouse MoAbs of the IgGl and IgG2a
Reagents.
Isolation and stainrng of platelets. The purity of the eosinophil preparation was approximately 90%. Basophils and monocytes were isolated by means of elutriation centrifugation. The purity of the monocyte and basophil suspensions was approximately 90% and SO%, respectively. The majority of the contaminating cells of the basophil fraction consisted of lymphocytes and a small percentage of monocytes and neutrophils. The monocyte fraction was contaminated with lymphocytes.28 Cell lines U937, ML-1, KGla, K562, HEL, ROS, and B-ALL were cultured in RPMI 1640 medium (GIBCO Laboratories, Grand Island, NY) supplemented with penicillin G (100 U/mL), streptomycin sulphate (100 pg/mL), and 10% fetal calf serum. All cell types were fixed with 1% PFA, incubated with appropriate MoAbs (Table l) , stained with fluorescein-isothiocyanate goat anti-mouse Ig (GAM-FITC, CLB, Amsterdam, The Netherlands), and treated with irrelevant mouse MoAbs as described above for staining of platelets.
Fixed immunostained cells and platelets were resuspended in 25 mmol/L Tris-HC1, pH 7.0/150 mmol/L NaC1/0.2% BSA, supplemented with either 1 mmol/L CaCl2 and 1 mmol/L MgC12, or 5 mmol/L EDTA (incubation buffer). Fifty microliters of the platelet suspension (1 x 1O8/mL) was mixed with 50 pL of the cell suspension (1 x 107/mL), giving a platelet to cell ratio of 101. After incubation for 30 minutes at room temperature, platelet-cell adhesion was quantitated by measuring red and green fluorescence on a FACScan cytometer (Becton Dickinson) using the Consort C30 double fluorescence program. The forward scatter-channel (FSC) was used as system trigger. The threshold (FSC) was set on a level high enough to exclude single platelets from data acquisition. The FL-1:FL-2 histogram was divided into quadrants using three control samples. The first contained cells incubated with a control antibody and stained with GAM-FITC as a negative control. The two other control samples were platelets and cells separately incubated with MoAb W6/32 and specific MoAbs (see Table l ), respectively, and each stained by fluorescent anti-IgG conjugates of a different color.
Antibody inhibition studies were performed by preincubating either the platelets or the leukocytes with ascites fluid (150 final dilution) or purified MoAbs (20 p,g/mL). Then, without washing, platelets and cells were gently mixed and the incubation was continued for an additional 30 minutes. Adhesion was measured as described above.
Neutrophils (l.107/mL RPMI) were treated with 10 p,L glycosylphosphatidyl inositol-specific phospholipase C (GPI-PLC; a kind gift of Dr M. Low, Columbia University, New York, NY) at a final dilution of 1:104 for 15 minutes at 37°C. Thrombin-activated platelets were treated with elastase or trypsin as described."
Neuraminidase (Vibrzo cholerae, Behringwerke, Marburg, Germany; Arthrobacter ureafaciens, Calbiochem-Behring, La Jolla, CA) treatment of cells was performed by incubating 1.106 cells in PBS/0.2% BSA (pH 7.4) with 0.2 U/mL neuraminidase for 60
Cell adhesion assay.
Treatment of cells with enzymes.
use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From minutes at 37°C. After treatment with enzymes, the cells were washed twice with PBS/0.2% BSA, fixed with PFA, and stained for detection by flow cytometry as described above.
RESULTS
P-selectin-mediated adhesion of thrombin-activated piatelets to monocytes, neutrophils, eosinophils, and basophils, measured by flow cytometty. In our initial experiments, monocytes, neutrophils, eosinophils, and basophils were prepared and stained as described in the Methods and their interaction with fixed thrombin-activated platelets was determined by light microscopy. It appeared that activated, but not resting, platelets adhere to monocytes and neutrophils, confirming previous results of Jungi et al,' and furthermore, that activated platelets also adhere to eosinophils and basophils.
To quantify the binding of activated platelets to eosinophils and to basophils, we have developed a double immunofluorescence assay, which involves the separate labeling of platelets and blood cells with specific MoAbs (Table 1) and with phycoerythrin-labeled rat MoAb against mouse IgG and GAM-FITC antibodies, respectively. After platelets and blood cells had interacted in a buffer containing Ca2+ and Mg2+, each at 1 mmol/L, binding was assessed by flow cytometry without additional washings. For reference, we also analyzed the binding of activated platelets to neutrophils and monocytes. Figure 1A shows the analysis of the interaction of activated platelets and eosinophils. The intensity of the red (platelets) and green fluorescence (eosinophils) is displayed on the abscissa and ordinate, respectively. Four subpopulations can be distinguished: quadrant 1, cells that oaly emit green fluorescence representing single eosinophils; quadrant 4, cells that only emit red fluorescence representing platelets (only small aggregates were detected in this quadrant); quadrant 2, platelet-eosinophil aggregates with both red and green fluorescence; and quadrant 3, nonfluorescent other cells. In this experiment, 85% of the eosinophils were complexed with platelets. When in the same sample adhesion was assessed by light microscopy, 79% of the eosinophils appeared to have bound two or more platelets. If directly fixed nonactivated platelets were used, which do not express P-selectin, only 8% of the Effect of anti-P-selectin MoAbs on platelet adhesion to eosinophils. Fixed isolated eosinophils and platelets were stained with MoAbs CLB-thromb/8 and W6/32, respectively (see Table 1 ) and subsequently with GAM-FITC and phycoerythrin-rat anti-mouse IgG. Eosinophils and platelets were mixed in a ratio of 1:lO and incubated for 30 minutes. The effects of the MoAbs were studied by preincubating the platelets with ascites fluid containing anti-P-selectin MoAbs 
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blocking effect on platelet-eosinophil interaction was observed with CLB-thromb/5 (Fig 1C) . Although platelets still bound to 64% of the eosinophils, a reduction in the mean immunofluorescence intensity indicates that fewer platelets had bound per eosinophil.
From Table 2 it can be seen that similar results were obtained when basophils were used and that adhesion of activated platelets to eosinophils and basophils seems to occur by the same mechanism as to neutrophils and monocytes, because (1) adhesion of activated platelets to eosinophils and basophils and to neutrophils and monocytes was dependent on added divalent cations, and (2) anti-P-selectin antibodies blocked binding of activated platelets to eosinophils and basophils and to neutrophils and monocytes.
P-selectindediated adhesion of thrombin-activated platelets to lymphocytes. Adhesion of lymphocytes to activated platelets has been noted previously, but nothing is known about the receptors involved and the subpopulation(s) of lymphocytes which in fact bind the platelets. To study this interaction, we have sensitized lymphocytes with specific MoAbs detecting either peripheral T lymphocytes (CD2), B lymphocytes (CD37), NK cells (CD16), T-helper cells (CD4), or T-suppressor cells (CD8), and quantified the interaction of activated platelets with these subpopulations using the double immunofluorescence assay. Because in these experiments the various T-cell subpopulations had not been further purified, aggregates of red fluorescent platelets and nonfluorescent T cells appeared in quadrant 4. This is an essential difference from the experiments described in Fig 1, in which the interaction of activated platelets with a single isolated cell population was determined.
Of the cells stained with either CD2, CD4, or CD8
MoAbs, 20% to 30% adhered to activated platelets (quadrants 2 in Fig 2) . Approximately 50% of the cells stained with a CD16 MoAb (a marker of NK cells) adhered to thrombin-activated platelets. Resting, directly fixed platelets, did not adhere to either the T-cell subsets or the NK cells. A summary of these experiments is given in Table 3 . In contrast to the results of Jungi et al,* we found that adhesion of activated platelets to lymphocytes was Ca2+-dependent (Table 3) . After depletion of CD16+ cells ( < 1% NK lymphocytes detectable), using the immunorosette depletion technique,29 in which red blood cells are sensitized with tetrameric complexes containing antiglycophorin A and CD16 MoAbs, the percentage of CD2+, CD4+, and CD8+ cells that bound to activated platelets was unaltered. After preincubating the platelets with MoAb CLBthromb/6, no adhesion was demonstrated (Table 3) , indicating that platelets also adhere to T cells and NK cells by P-selectin.
Adhesion of thrombin-activated platelets to different cell lines. To further study the distribution of the ligand for P-selectin, we have investigated the adhesion of activated platelets to a number of in vitro cell lines. It has been reported that platelets can interact via P-selectin with the cell lines U937 and HL60. 2 Our data confirm that activated, but not resting, platelets adhere to U937 cells in a P-selectin, Ca2+-dependent manner (Table 4 ). In addition, we found that activated, but not resting, platelets adhere to the cell line KGla (myeloid origin). Again, the adhesion to KGla cells was dependent on divalent cations, since it was strongly inhibited by EDTA. All other cell lines tested, ML-1 (myeloid origin), K562, and HEL (both megakaryocytic, erythroid origin), ROS (Burkitt type cell line), and B-ALL (B cell line), failed to adhere to both resting and thrombin-activated platelets (Table 4) . Treatment of neutrophils, monocytes, eosinophils, and basophils with neuraminidase from vibrio cholerae decreased binding of all four cell types to activated platelets, but the degree of reduction in binding appeared to vary (Table 5) . While binding to neutrophils was decreased to 15%, when compared with sham-treated controls, the effect on binding to monocytes, eosinophils, and basophils appeared to be less pronounced: approximately 60% of these cells still bound activated platelets. Similar results were observed when a fivefold higher concentration of neuraminidase or when neuraminidase from Arthrobacter ureafaciens was used. Furthermore, longer incubations of the cells with neuraminidase did not alter the percentage of binding. The efficacy of the treatment with neuraminidase was demonstrated by the complete loss of the reactivity of the anti-sialyl-Lex antiCharacterization of the ligand for P-selectin. body CSLEX-1 with all four different types of leukocytes (Table 5) . It was already shown above that the binding of platelets to all four cell types could be prevented by MoAb CLBthromb/6 against P-selectin. Because the residual binding after neuraminidase could also be fully inhibited by MoAb CLB-thromb/6 (not shown), the recognition structure for P-selectin may include, in addition to sialic acid residues, other determinants. Alternatively, P-selectin may bind to two distinct ligands, one sensitive to neuraminidase treatment and present predominantly on neutrophils, and a second, insensitive to neuraminidase treatment and primarily expressed by monocytes, eosinophils, and basophils.
To investigate whether the ligand for P-selectin might be PI-linked, we used neutrophils and monocytes from a patient with paroxysmal nocturnal hemoglobinuria (PNH), which are deficient in PI-linked proteins.3O Neutrophils and monocytes of a patient with PNH and of a healthy volunteer were tested with a panel of MoAbs directed against PI-linked proteins (Table 6 ). Because the monocytes of the patient with PNH failed to react with the anti-CD14 MoAb (directed against a PI-linked surface antigen), we used a Subpopulations of lymphocytes were stained with specific MoAbs (see Table 1 Table 1 ), mixed with resting or activated platelets, and incubated for 30 minutes under the conditions indicated. The adhesion was measured by flow cytometry as described in Materials and Methods. Values for U937 and KGla cells are the means of three and two measurements, respectively.
CD36 MoAb to sensitize the monocytes for the adhesion assay. The adhesion of activated platelets to neutrophils and monocytes, missing several PI-linked proteins, appeared to be normal (Table 6 ). We also studied the effect of treatment of normal neutrophils with GPI-PLC, an enzyme that cleaves the PI-linkage. The binding of CD24 and CD16 MoAbs (both directed against PI-linked surface antigens on neutrophil^^^,^^) was reduced to 71% and 31%, respectively, on GPI-PLC-treated neutrophils. Also, their capacity to adhere to thrombin-activated platelets was normal (not shown). Taken together, these results suggest that at least part of the ligands for P-selectin on neutrophils and monocytes are not PI-linked. It has been suggested that the pentasaccharide LNF I11 (also called CD15 antigen or Lex) is the principal ligand for P-selectin on neutrophils and monocytes, since CD15 MoAbs and soluble Lex oligosaccharides block this interaction.14 We have tested the inhibitory effect of Lex and LNF I (a control oligosaccharide) in a concentration range from Sialyl-L@ and Le* are not per se ligands for P-selectin. Leukocytes were incubated with 0.2 UImL of Vibrio cholerae neuraminidase for 1 hour at 37°C and control leukocytes for the same period of time without enzyme. Treated and untreated cells were then incubated with anti-sialyl-Lex (CSLEX-1) MoAb and the bound antibody was detected by reaction with GAM-FITC. The mean fluorescence (of the gated population) was measured by flow cytometry. Adhesion of thrombin-activated platelets to neuraminidase-treated and -untreated leukocytes was determined as described in Materials and Methods. The number of experiments is shown in parentheses and the results are the means of the results of these experiments. Antibody binding to neutrophils and monocytes from a control donor and a patient with PNH was detected by reaction with GAM-FITC. followed by flow cytometry. MoAbs CD24, CD16, CD67, and CD14 are directed against PI-linked antigens. MoAbs CD15 and CD36 were used as markers for neutrophils and monocytes, respectively. The mean fluorescence (MF) of the gated population was measured by flow cytometry. Adhesion assays were performed as described in Materials and Methods.
25 to 200 pg/mL on the binding of activated platelets to neutrophils and monocytes, but failed to detect any inhibition. The involvement of CD15 in P-selectin recognition was also tested by studying the effects of a panel of CD15 MoAbs from our laboratory (CLB-gran/2= and CLB-3B99 and of CD15 MoAbs obtained via the Workshop on Leukocyte Typing IV. 25 No effect of any of these reagents on binding could be demonstrated. To further examine whether Lex is involved in P-selectin recognition, we studied whether the expression of CDl5 on the cell lines used above is correlated with their ability to bind activated platelets. As shown in Table 7 , monocytes, basophils, and Neutrophils were treated with proteases or neuraminidase as described in the Methods. Cell surface expression of Lex and sialyl-Lex was assessed as described in the Table 7 notes. The mean fluorescence (MF) of the total neutrophil population was measured by flow cytometry. Platelet adhesion was assessed as described in Materials and Methods.
KGla cells, which adhere avidly to activated platelets, do not or only weakly express the CD15 antigen. Furthermore, ML-1 cells, which strongly express CD15, do not bind activated platelets. Finally, it should be mentioned that neutrophils treated with neuraminidase, elastase, or trypsin had almost completely lost the capacity to bind activated platelets, but their reactivity with CD15 MoAbs was not diminished (Table 8) . Taken together, these results indicate that CD15 per se can not be the ligand for P-selectin. Similar to the experiments described above for Lex, experiments were performed with sialyl-Lex oligosaccharides (final concentrations, 0.5 to 50 kg/mL) and anti-sialylLex MoAb CSLEX-1 (final concentrations, 0.5 to 100 pg/mL). None of these reagents affected the binding of activated platelets to monocytes and neutrophils. However, there was a close correlation between the expression of sialyl-Lex on cells and their ability to bind activated platelets (Table 8) . Therefore, sialyl-Lex might still be involved in P-selectin recognition, probably not as a simple tetrasaccharide, but as part of a more complex oligosaccharide. Furthermore, P-selectin may additionally recognize protein components, since treatment of neutrophils and monocytes with elastase and trypsin markedly diminished the binding of activated platelets, while the reactivity of the MoAb CSLEX-1 remained unaltered (Table 8) .
DISCUSSION
The results of the present study show that the double immunofluorescence technique is a useful assay to quantify the adhesion of activated platelets to different types of peripheral blood cells. Particularly, the interaction of platelets with subpopulations of cells for which specific MoAbs are available, can be studied without isolating the subpopulations.
Our results show that activated platelets adhere not only to neutrophils and monocytes, but also to eosinophils, basophils, NK cells, and a second, undefined subpopulation of peripheral T lymphocytes in both CD4 and CD8 subsets. Only thrombin-stimulated platelets, but not resting platelets, adhered. Adhesion of activated platelets to eosinophils and basophils is dependent on divalent cations, since no adhesion was observed in a medium containing 5 mmol/L that the adhesion of platelets to lymphocytes (including NK cells) is also Ca2+-dependent.
The receptor on activated platelets responsible for the interactions with the different leukocyte subpopulations appeared to be P-selectin in all cases. The MoAb CLBthromb/6 completely blocked the interaction of activated platelets with leukocytes, whereas MoAb CLB-thromb/S blocked only partially. The MoAbs RUU 1.18, RUU 2.15, and RUU 2.17 had no effect on binding. In a previous we have shown that there are several distinct epitopes on P-selectin. The epitopes detected by the MoAbs CLB-thromb/S and CLB-thromb/6 are sensitive to treatment with elastase and trypsin, whereas the epitopes recognized by RUU 1.18, RUU 2.15, and RUU 2.17 are not. Moreover, treatment of activated platelets with neuraminidase reduced the expression of the epitope recognized by CLB-thromb/6 by 50%. Thus, both protein and sialic acid residues may be part of the CLB-thromblb defined epitope. The expression of this epitope is closely associated with the function of P-selectin as an adhesion receptor, since its destruction by either protease or neuraminidase treatment diminished the ability of activated platelets to bind to neutrophils (data not shown). This corroborates the blocking effect found with the CLBthromb/6 MoAb. P-selectin belongs to the selectin family4 of adhesion proteins, which includes the endothelial leukocyte adhesion molecule (ELAM-1 or E-selectin) and the lymphocyte homing receptor (MEG14/LAM-1 or L-selectin). The members of this family are characterized by a unique primary structure, containing a lectin domain, that is thought to recognize carbohydrates on their ligand structures.
Larsen et all4 concluded that P-selectin recognizes the Lex (CD15) antigen, since adhesion of neutrophils to activated platelets was partially inhibited both by MoAbs against Lex (CD15) and by soluble oligosaccharides containing the Lex structure. On the contrary, other investigators found that (1) the binding of P-selectin to neutrophils was not blocked by an anti-CD15 antibody or by multivalent Lex-BSA conjugates?l and (2) treatment of neutrophils with neuraminidase blocked binding of activated platelets, suggesting that sialic acid residues are an essential component of the adhesion site.20.2* In our study, we found that neither a series of MoAbs against CD15 nor Lex in high concentrations inhibited the binding of activated platelets to neutrophils. Finally, we found no correlation between expression of Lex (CD15) and the ability of cells to bind activated platelets. The conclusion from our results therefore is that Lex cannot be a major ligand for P-selectin.
Other studies have suggested that as for E-~electin?~ sialyl-Lex is the ligand for P-sele~tin.l~,*~ Indeed, we found a good correlation between expression of sialyl-Lex and the ability of cells to bind activated platelets. However, we did not find that an MoAb against sialyl-Lex or, like Aruffo et al,19 that soluble oligosaccharides containing the sialyl-Lex structure had any inhibitory effect. There is no satisfactory use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From explanation for the discrepant results obtained with sialylLex, except that the blocking capacity of sialyl-LeX in different preparations might differ or that sialyl-Lex is not the sole ligand for P-selectin. The involvement of other ligands than sialyl-lex in P-selectin-mediated adhesion is also suggested by our observations that (1) neuraminidase treatment of monocytes, eosinophils, and basophils destroyed the reactivity of the anti-sialyl-Lex antibody CSLEX-1, but only partially inhibited the binding of activated platelets to these cells, and (2) protease treatment of myeloid cells markedly diminished adhesion of activated platelets, although a normal amount of sialyl-LeX could still be detected. In fact, two other groups have obtained evidence for the existence of multiple ligands for P-selectin. They found that P-selectin binds to sulfatidesZO and, moreover, that binding of P-selectin to neutrophils and HL60 cells could be inhibited by heparin, fucoidin, and dextran s~l f a t e .~~J~ All these molecules are negatively charged and, therefore, apart from sialylation, other types of anionic modification of oligosaccharides, such as sulfation and phosphorylation, may contribute to P-selectin recognition. Our finding that the P-selectin-mediated adhesion is sensitive to proteases would argue against the possibility that sulfatides themselves are essential components of the ligand for P-selectin.
It is not clear from our data whether the protein components are directly recognized by P-selectin or whether they are important for the proper exposure of the oligosaccharide structures. Binding studies performed with neutrophils and monocytes from a patient with PNH and with normal cells treated with GPI-PLC indicated that the ligands for P-selectin are probably not PI-linked proteins.
